Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

Across a large conference room table somewhere inside the bowels of the Wynn Las Vegas, the members of Grupo Frontera appeared tired. The Tex-Mex quintet had been shuffling up and down the Las Vegas ...

Thailand SET offers exposure to a diversified basket of stocks, which can be appealing for investors seeking broad market exposure. Investing in the index can be done through various methods such as ...

Chinese electric vehicle makers are increasingly focused on Latin America and the Caribbean, investing heavily in this growing market of 665 million people. Brazil, Chile, and Argentina are the latest ...